---
title: "ZYBT.US (ZYBT.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ZYBT.US/news.md"
symbol: "ZYBT.US"
name: "ZYBT.US"
parent: "https://longbridge.com/zh-HK/quote/ZYBT.US.md"
datetime: "2026-03-11T03:28:48.196Z"
locales:
  - [en](https://longbridge.com/en/quote/ZYBT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ZYBT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ZYBT.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/ZYBT.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/ZYBT.US/news.md)


# ZYBT.US (ZYBT.US) — 相關新聞

### [U.S. stock market midday update: Zhengye Biotechnology down 8.47%, clear capital flow, industry volatility attracts market attention](https://longbridge.com/zh-HK/news/277093146.md)
*2026-02-26T20:47:55.000Z*
> Zhengye Biotechnology fell 8.47%; Eli Lilly fell 0.79%, with a transaction volume of USD 1.904 billion; Johnson & Johnso

### [Zhengye Biotechnology Holding Ltd. Outlines 2026 Strategy Focused on Expanding Poultry Vaccine Sales, Strengthening Swine Health Business, and Enhancing Market Share Among Large-Scale Livestock Producers](https://longbridge.com/zh-HK/news/275466886.md)
*2026-02-10T13:30:51.000Z*
> Zhengye Biotechnology Holding Ltd. has outlined its 2026 strategy focusing on expanding poultry vaccine sales and streng

### [Zonsen Peplib Biotech Enters Global Research And Development Collaboration And License Agreement With Lilly](https://longbridge.com/zh-HK/news/274664190.md)
*2026-02-03T13:25:23.000Z*
> Feb 3 (Reuters) - Eli Lilly and Co (LLY.N) :* ZONSEN PEPLIB BIOTECH ENTERS GLOBAL RESEARCH AND DEVELOPMENT COLLABORATION

### [Biotech Stocks Facing FDA Decision In February 2026](https://longbridge.com/zh-HK/news/273929972.md)
*2026-01-28T03:45:32.000Z*
> The FDA approved 46 novel drugs in 2025, with 70% receiving approval in the U.S. first. As January 2026 ends, attention 

### [Zydus Lifesciences shares in focus after USFDA issues observations](https://longbridge.com/zh-HK/news/273776739.md)
*2026-01-27T02:40:25.000Z*
> Zydus Lifesciences shares are under scrutiny following three observations from the USFDA after an inspection at its Ankl

### [Zydus Lifesciences says USFDA inspection closed with 2 observations for Ankleshwar unit-2 plant](https://longbridge.com/zh-HK/news/273514948.md)
*2026-01-23T12:20:41.000Z*
> Zydus Lifesciences says USFDA inspection closed with 2 observations for Ankleshwar unit-2 plant

### [U.S. stock market update: Zhengye Biotechnology up 26.03%](https://longbridge.com/zh-HK/news/259565086.md)
*2025-09-30T14:33:02.000Z*
> Zhengye Biotechnology rose 26.03%; Pfizer rose 4.39%, with a transaction volume of USD 886 million; Eli Lilly rose 0.78%

### [U.S. stock market update: Zhengye Biotechnology up 13.59%](https://longbridge.com/zh-HK/news/259390481.md)
*2025-09-29T18:02:59.000Z*
> Zhengye Biotechnology rose 13.59%; Eli Lilly fell 0.09%, with a trading volume of USD 1.344 billion; Novo Nordisk fell 0

### [Pre-market hot trades in US stocks: Zhengye Biotechnology up 12.07% in pre-market; Platinum Analytics Cayman - CL down 7.80% in pre-market](https://longbridge.com/zh-HK/news/258843850.md)
*2025-09-25T09:37:06.000Z*
> Zhengye Biotechnology pre-market up 12.07%; Platinum Analytics Cayman - CL pre-market down 7.80%; PepGen pre-market up 1

### [Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday](https://longbridge.com/zh-HK/news/258751610.md)
*2025-09-24T18:18:13.000Z*
> U.S. stocks fell on Wednesday, with the Dow Jones dropping over 150 points. Freeport-McMoRan Inc. shares plummeted 16.4%